Module 02 Course Project - Identify Business Requirements
Gladiola
AnoxPharmaceticusMeeting.docx<Project Name> Version: 1.0 Error! Unknown document property name.
Anox Pharmaceticus
Anox Pharmaceticus
Sales Consulant Analysis
Meeting Minutes
Meeting Date: 01/15/2015
Meeting Location: CCO Office
Project Sponsor: Robert M. Lopez, CCO
ANox Pharmaceutics
Sales Consultant Analysis Meeting Date 01/15/2015
Meeting Minutes Page 2 of 3
Attendance
|
Name |
Title |
Organization |
Present |
|
Robert M. Lopez |
Chief Compliance Officer |
ANox Pharmaceutics |
Yes |
|
|
|
|
|
|
|
|
|
|
Meeting Location
Building: 3
Conference Room: 217
Conference Line: NA
Web Address: NA
Agenda
· Welcome project team
· Business case for this project
· Expectations and Deliverables
· Timeline
Meeting Notes
Robert M. Lopez opened the meeting by welcoming the project team and expressing the importance of this project as it relates to ANox Pharmaceutics. ANox pharmaceutics will be subject to a government audit within the next 6 months for sales consultants. Mr. Lopez is expected to report to a sub committee.
It has been brought to his attention that sales consultants are not adhering to ANox policy. This could put the organization at risk.
Mr. Lopez expects this team to provide:
· Summary of sales consultants not adhering to policy
· Sales consultants that may be in policy but behaviors are trending toward noncompliance.
Mr. Lopez expressed the need not only to look for outliners using ANox Pharmaceutics
Sales Consultant Selling Practices Policy P1029 – Year 2014, but to analyze the data beyond the policy and look for any trends that may indicate potential noncompliance of the policy.
1
Revision Date: Error! Unknown document property name.
Approval Date: <Date or 'DRAFT'> Page 3 of 3
